Duodenal ESD/EFTR success depends on more than resection
fibrosis recognition and reliable defect closure matter.

Duodenal ESD/EFTR success depends on more than resection
fibrosis recognition and reliable defect closure matter.
What if appendiceal adenocarcinoma shouldn’t simply be treated like colon cancer?
New data suggest recurrence risk varies sharply by histology—and the benefit of routine adjuvant chemotherapy may be less straightforward than assumed.
Worth a closer look.